Type 2 diabetes mellitus patients showed a decrease in plasma concentrations of SFRP5 which were unfavorably related to the evaluation of the homeostatic insulin resistance model, suggesting that SFRP5 could play a defensive action in the pathogenesis of T2DM (Hu Z. et al., 2013). The gene discussed is SFRP5; the disease is diabetes mellitus.